Avacta Group plc (AIM: AVCT), a life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics, announces it has granted a total of 2,500,000 options over ordinary shares of 10p each to certain directors of the Company (the Options ).

Dr Eliot Forster, Chairman of Avacta Group plc said: Following the completion of the 2020 LTIP award period and the significant progress made within the Group during the year, I am pleased to confirm that the Remuneration Committee has been able to conclude the changes to the equity arrangements of Alastair and Tony. These arrangements continue to align the interest of the Executive Directors with the longer-term share price performance interests of our shareholders.

Contact:

Tel: +44 (0)20 3871 9700

(C) 2023 Electronic News Publishing, source ENP Newswire